Bright Minds Biosciences, Inc. (DRUG)
52.43
+0.43
(+0.83%)
USD |
NASDAQ |
Oct 08, 16:00
52.00
-0.43
(-0.82%)
After-Hours: 20:00
Bright Minds Biosciences EPS Diluted (Quarterly) : -0.1762 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1762 |
| March 31, 2026 | -0.7951 |
| December 31, 2025 | -0.6991 |
| September 30, 2025 | -0.4139 |
| June 30, 2025 | -0.5345 |
| March 31, 2025 | -0.2921 |
| December 31, 2024 | 0.0053 |
| September 30, 2024 | -0.1253 |
| June 30, 2024 | 0.0361 |
| March 31, 2024 | -0.0954 |
| December 31, 2023 | -0.3218 |
| September 30, 2023 | -0.302 |
| June 30, 2023 | -0.2879 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.4003 |
| December 31, 2022 | -0.4796 |
| September 30, 2022 | -0.7601 |
| June 30, 2022 | -0.8775 |
| March 31, 2022 | -1.495 |
| December 31, 2021 | -1.627 |
| September 30, 2021 | -0.9613 |
| June 30, 2021 | -1.216 |
| March 31, 2021 | -0.6364 |
| December 31, 2020 | -0.4515 |
| March 31, 2020 | -0.0023 |
| December 31, 2019 | -0.0186 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 4.366 |
| Lineage Cell Therapeutics, Inc. | -0.0304 |
| Recursion Pharmaceuticals, Inc. | -0.246 |
| Agenus, Inc. | -0.0146 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.732M |
| Total Expenses (Quarterly) | 1.732M |
| Enterprise Value | 296.01M |
| Earnings Yield | -3.98% |
| Normalized Earnings Yield | -3.975 |